市場調查報告書
商品編碼
1392175
可操縱針市場 - 按類型(斜尖軟性針、對稱尖針、肌腱驅動尖)、應用(活體組織切片、腫瘤消融、疼痛管理、機器人輔助手術)、最終用途 - 全球預測,2023-2032Steerable Needles Market - By Type (Bevel-tip Flexible Needles, Symmetric-tip Needles, Tendonactuated Tips), Application (Biopsy, Tumor Ablation, Pain Management, Robotic Assisted Surgery), End-use - Global Forecast, 2023-2032 |
由於產品不斷推出和政府批准,2023 年至 2032 年間,全球可轉向針市場的複合CAGR將達到 6.7%。創新針設計的引入提高了精度和可操作性,推動了市場的成長。
例如,2023 年 9 月,Serpex Medical 宣布其 Compass Steerable Needles 獲得美國 FDA 510(k) 批准。這些針專門設計用於在活體組織切片過程中精確進入肺內肺結節。 Serpex Medical 旨在利用可操縱儀器的潛力來提高準確性和可及性,從而推進肺癌的診斷和治療。 Compass Steerable Needles 的批准是在 Serpex 的 Recon Steerable Sheath 最近獲得批准之後獲得的,這標誌著該公司創新醫療工具的連續監管里程碑。
再加上確保安全性和有效性的監管批准,這些進步吸引了尋求改善微創手術手術結果的醫療保健提供者和機構。隨著新產品進入市場和監管機構認可其使用,可操縱針的市場需求不斷擴大,以滿足不同的醫療專業和程序。
整個可操縱針市場根據應用、最終用戶和地區進行分類。
腫瘤消融領域將在 2023 年至 2032 年間經歷重大發展。這些專用針能夠在射頻和微波消融等微創干預期間實現精確定位和治療。醫療保健提供者越來越依賴這些創新工具來接近具有挑戰性的解剖位置的腫瘤,為患者提供風險更低、恢復時間更短的微創治療選擇。隨著對有效腫瘤消融技術的需求上升,在腫瘤護理和介入放射學進步的推動下,可操縱針的市場前景持續擴大。
門診手術中心細分市場從 2023 年到 2032 年將實現顯著的CAGR。這些中心優先考慮手術的精確性和效率,推動專用可操縱針的採用。這些針能夠導航複雜的解剖路徑並靶向特定組織,從而提高了活體組織切片、消融和藥物輸送的準確性。隨著門診護理的成長,對多功能、精確工具的需求不斷升級,可操縱針成為提供有效、微創治療的重要工具,有助於可操縱針市場佔有率的不斷擴大。
歐洲可操縱針產業從 2023 年到 2032 年將呈現出值得稱讚的CAGR。該地區對微創手術的傾向和介入放射學的進步推動了精確可操縱針的採用。他們能夠進入具有挑戰性的解剖部位進行活體組織切片、腫瘤消融和治療,這符合歐洲改善患者治療結果和減少住院時間的醫療保健目標。隨著醫療機構優先考慮微創方法,對創新可操縱針的需求持續成長,從而塑造了整個歐洲醫療干預的不斷擴大的格局。
Global Steerable Needles Market will witness 6.7% CAGR between 2023 and 2032, attributed to the continuous stream of product launches and government approvals. The introduction of innovative needle designs that offer enhanced precision and maneuverability fuels market growth.
For instance, in September 2023, Serpex Medical unveiled the clearance by the U.S. FDA under 510(k) for its Compass Steerable Needles. These needles are specifically designed for precise access to intrapulmonary lung nodules during biopsies. Serpex Medical aims to harness the potential of steerable instruments to enhance accuracy and accessibility, thereby advancing the diagnosis and treatment of lung cancer. The approval of the Compass Steerable Needles comes after the recent clearance of Serpex's Recon Steerable Sheath, marking successive regulatory milestones for the company's innovative medical tools.
Coupled with regulatory approvals that ensure safety and efficacy, these advancements attract healthcare providers and institutions seeking improved procedural outcomes in minimally invasive surgeries. As new products enter the market and regulatory bodies endorse their use, the steerable needles market demand amplifies, catering to diverse medical specialties and procedures.
The overall Steerable Needles Market is classified based on application, end-user, and region.
Tumour ablation segment will undergo significant development from 2023 to 2032. These specialized needles enable precise targeting and delivery of therapies during minimally invasive interventions, such as radiofrequency and microwave ablation. Healthcare providers increasingly rely on these innovative tools to access tumors in challenging anatomical locations, offering patients minimally invasive treatment options with reduced risks and shorter recovery times. As the demand for effective tumor ablation techniques rises, the steerable needles market outlook continues to expand, driven by advancements in oncology care and interventional radiology.
Ambulatory surgical centers segment will register a noteworthy CAGR from 2023 to 2032. These centers prioritize precision and efficiency in procedures, driving the adoption of specialized steerable needles. With their ability to navigate complex anatomical pathways and target specific tissues, these needles offer enhanced accuracy in biopsy, ablation, and drug delivery. As ambulatory care grows, the demand for versatile, precise tools escalates, positioning steerable needles as vital instruments in providing effective, minimally invasive treatments, thus contributing to the continuous expansion of the steerable needle market share.
Europe steerable needles industry will showcase a commendable CAGR from 2023 to 2032. The region's inclination towards minimally invasive procedures and advancements in interventional radiology fuels the adoption of precise steerable needles. Their ability to access challenging anatomical sites for biopsies, tumor ablation, and therapeutic delivery aligns with Europe's healthcare goals of improved patient outcomes and reduced hospital stays. As healthcare facilities prioritize minimally invasive approaches, the demand for innovative steerable needles continues to grow, shaping the expanding landscape of medical interventions across Europe.